POLONELLI, Luciano
 Distribuzione geografica
Continente #
NA - Nord America 14.980
AS - Asia 14.840
EU - Europa 10.954
SA - Sud America 3.182
AF - Africa 864
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 10
Totale 44.849
Nazione #
US - Stati Uniti d'America 14.436
SG - Singapore 5.719
CN - Cina 4.218
VN - Vietnam 2.637
BR - Brasile 2.533
UA - Ucraina 2.122
IE - Irlanda 1.813
DE - Germania 1.663
SE - Svezia 1.225
FI - Finlandia 1.188
HK - Hong Kong 996
IT - Italia 948
ZA - Sudafrica 628
FR - Francia 558
NL - Olanda 550
CA - Canada 400
RU - Federazione Russa 282
AR - Argentina 275
TR - Turchia 241
GB - Regno Unito 207
IN - India 170
BD - Bangladesh 142
AT - Austria 134
EC - Ecuador 128
IQ - Iraq 108
ID - Indonesia 85
MX - Messico 84
JP - Giappone 78
PK - Pakistan 60
CO - Colombia 55
MA - Marocco 53
PY - Paraguay 50
ES - Italia 46
BE - Belgio 45
UZ - Uzbekistan 43
PL - Polonia 41
VE - Venezuela 41
KE - Kenya 39
PH - Filippine 39
CL - Cile 38
EG - Egitto 36
SA - Arabia Saudita 30
TH - Thailandia 30
TN - Tunisia 30
TW - Taiwan 28
PE - Perù 24
AE - Emirati Arabi Uniti 23
KR - Corea 22
UY - Uruguay 21
NP - Nepal 20
JO - Giordania 19
AZ - Azerbaigian 18
IL - Israele 18
EU - Europa 15
CZ - Repubblica Ceca 14
KZ - Kazakistan 14
BG - Bulgaria 13
BO - Bolivia 13
LB - Libano 13
LT - Lituania 13
DO - Repubblica Dominicana 12
DZ - Algeria 12
RO - Romania 12
AL - Albania 10
CI - Costa d'Avorio 9
CR - Costa Rica 9
ET - Etiopia 9
HU - Ungheria 9
MY - Malesia 9
PA - Panama 9
BY - Bielorussia 8
RS - Serbia 8
AU - Australia 7
BH - Bahrain 7
OM - Oman 7
BA - Bosnia-Erzegovina 6
HN - Honduras 6
HR - Croazia 6
NG - Nigeria 6
PS - Palestinian Territory 6
AO - Angola 5
KG - Kirghizistan 5
LK - Sri Lanka 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BW - Botswana 4
CH - Svizzera 4
GA - Gabon 4
GE - Georgia 4
JM - Giamaica 4
KW - Kuwait 4
LU - Lussemburgo 4
MN - Mongolia 4
MU - Mauritius 4
NI - Nicaragua 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TG - Togo 4
Totale 44.784
Città #
Singapore 2.270
Jacksonville 2.243
Dublin 1.810
Ashburn 1.245
Chandler 1.158
San Jose 1.153
Beijing 1.056
Hong Kong 951
Ho Chi Minh City 883
Dearborn 780
Nanjing 647
Boardman 609
Santa Clara 595
Johannesburg 580
Hanoi 579
San Mateo 570
Dallas 543
Princeton 504
Lauterbourg 441
Toronto 322
Des Moines 264
Ann Arbor 245
Bremen 243
Helsinki 221
Moscow 220
Wilmington 216
São Paulo 194
Shenyang 191
Los Angeles 187
Izmir 184
Munich 180
Kunming 171
Nanchang 167
Hefei 162
Hebei 160
New York 157
Parma 140
Vienna 125
Shanghai 124
Buffalo 119
Haiphong 107
Jinan 105
Düsseldorf 103
Grafing 101
Tianjin 93
Da Nang 90
Changsha 89
Jiaxing 74
Guangzhou 73
Rio de Janeiro 73
Seattle 62
Fremont 61
Brasília 57
Quito 53
Woodbridge 52
Biên Hòa 50
Houston 48
Frankfurt am Main 47
Marseille 47
Tokyo 45
Curitiba 44
Fortaleza 44
Brussels 43
Hải Dương 43
Turku 42
Columbus 40
Milan 39
Porto Alegre 38
Baghdad 37
Tashkent 37
Can Tho 36
Norwalk 36
Salvador 36
Hangzhou 34
Rome 34
Belo Horizonte 33
Brooklyn 33
Nairobi 33
Orem 32
Bắc Ninh 29
Chennai 29
Thái Bình 29
Council Bluffs 28
Guayaquil 28
Warsaw 28
Zhengzhou 27
Atlanta 26
Campinas 26
Thái Nguyên 26
Chicago 25
Montreal 25
San Francisco 24
Buenos Aires 23
London 23
Manaus 23
Borås 22
Chengdu 22
Wuhan 21
Asunción 20
Casablanca 20
Totale 25.277
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 281
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 227
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 210
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 200
Il problema dell’antibiogramma nelle infezioni da funghi filamentosi. 196
Antibodies as a source of anti-infective peptides: an update 189
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 185
A synthetic peptide as a novel anticryptococcal agent 182
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 180
Antibiocorpi: Anticorpi anti-idiotipo ad attività antibiotica in vivo ed in vitro 174
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 174
Metabolic profiling of Candida albicans 173
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 172
Antifungal peptides within the antibodies 170
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 167
Fungicidal activity of peptides encoded by immunoglobulin genes 165
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 165
Antifungal activity of the C-terminal peptide from human serum albumin 162
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 162
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 162
L’antibiogramma per i miceti 161
Micologia Clinica. Manuale di Laboratorio. 160
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 157
Anaerobic yeast killer system. 153
Antibody peptide based antifungal immunotherapy 153
Peptides from the inside of the antibodies are active against infectious agents and tumours 152
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 151
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 150
Caratterizzazione ed isotipizzazione di anticorpi monoclonali murini anti-laminarina con potenziale attività candidacida. 150
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 149
Antibody-mediated protective immunity in fungal infections 149
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 149
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 148
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 148
Anticorpi immagini interne di tossine killer 148
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 148
Natural and synthetic peptides with antifungal activity 147
Antibiobodies: antibiotic-like antiidiotypic antibodies. 144
AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model 141
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 140
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 140
Oral and maxillofacial fungal infections 140
Antibiocorpi: anticorpi anti-idiotipo ad attività antibiotica 138
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 136
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 136
Activity of nitroimidazole derivative synthetic compounds on Trichomonas vaginalis and Candida albicans isolates 135
Antireceptor yeast killer toxin-like antibiobodies 135
Mode of action of a killer peptide against Toxoplasma gondii 135
Chimeric symbionts expressing a Wolbachia protein stimulate mosquito immunity and inhibit filarial parasite development 135
Antibiobodies: antibiotic internal image antibodies 134
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 134
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 134
Conformation-sensitive Antibodies against Alzheimer Amyloid-beta by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide 133
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 132
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 132
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 132
Metabolic profile of Candida albicans 131
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 131
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 131
A case of disseminated fatal infection caused by Nocardia caviae. 130
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 129
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 129
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 129
Cases of imported malaria in Parma observed in the period January-September 1994 128
A multicenter study of the in vitro activity of voriconazole against 1,996 yeast and 192 mould clinical isolates 127
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 126
Antibiotic antibodies 125
A microautomated dilution method for susceptibility testing with antifungal drugs. 124
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 124
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo 124
Caratterizzazione dell'epitopo polisaccaridico reattivo con IgA secretorie della mannoproteina maggiore da stress secreta da Candida albicans. 124
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 124
In vitro and in vivo anticandidal activity of killer peptide derivatives 124
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 123
Innate antimicrobial and antiviral activities of antibody peptides 122
Actinomiceti. 122
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 120
Marcatori epidemiologici. 118
Restriction of Influenza virus multiplication induced by PK peptide treatment 118
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 117
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 117
Involvement of beta-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin 116
Anti-idiotypic vaccination against group B streptococci 115
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 113
Antibodies as Crypts of Antiinfective and Antitumor Peptides 112
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 112
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 112
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 111
Candidacidal properties of peptides encoded by immunoglobulin genes 111
A novel glyco-conjugate vaccine against fungal pathogens 110
Caratterizzazione antigenica di Microsporum canis, M. distortum, M. ferrugineum e Trichophyton soudanense. 109
Immagine interna del fenomeno killer dei lieviti 109
Any antibody fragment might exert antifungal activity 109
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 108
Yeast killer toxins and dimorphism. 108
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 107
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 107
Human natural yeast killer toxin-like antibodies 106
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 106
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 105
Totale 14.058
Categoria #
all - tutte 153.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021563 0 0 0 0 0 0 0 0 0 40 502 21
2021/20222.384 23 6 7 50 83 111 333 458 97 285 95 836
2022/20235.790 940 414 267 308 585 607 48 289 2.149 20 111 52
2023/20241.866 105 189 65 53 189 511 50 100 20 133 167 284
2024/20256.781 43 565 563 307 587 571 107 210 1.281 855 464 1.228
2025/202615.660 1.128 1.804 2.195 2.316 2.308 873 1.962 518 1.864 692 0 0
Totale 45.011